|
1
|
Jahangeer S, Forde P, Soden D and Hinchion
J: Review of current thermal ablation treatment for lung cancer and
the potential of electrochemotherapy as a means for treatment of
lung tumors. Cancer Treat Rev. 39:862–871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li
CP and Chou YJ: Pulmonary tuberculosis increases the risk of lung
cancer: A population-based cohort study. Cancer. 117:618–624. 2011.
View Article : Google Scholar
|
|
3
|
Kerkentzes K, Lagani V, Tsamardinos I,
Vyberg M and Røe OD: Hidden treasures in 'ancient' microarrays:
gene-expression portrays biology and potential resistance pathways
of major lung cancer subtypes and normal tissue. Front Oncol.
4:2512014. View Article : Google Scholar
|
|
4
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Long BH and Fairchild CR: Paclitaxel
inhibits progression of mitotic cells to G1 phase by interference
with spindle formation without affecting other microtubule
functions during anaphase and telephase. Cancer Res. 54:4355–4361.
1994.PubMed/NCBI
|
|
6
|
Patel S and Goyal A: Recent developments
in mushrooms as anticancer therapeutics: A review. Biotech. 2:1–15.
2012.
|
|
7
|
Hadeler H: Medicinal Mushrooms You Can
Grow. Cariaga Publishing House. 1995.
|
|
8
|
Lee KH, Morris-Natschke SL, Yang X, Huang
R, Zhou T, Wu SF, Shi Q and Itokawa H: Recent progress of research
on medicinal mushrooms, foods, and other herbal products used in
traditional Chinese medicine. J Tradit Complement Med. 2:84–95.
2012.PubMed/NCBI
|
|
9
|
Xu X, Yan H, Tang J, Chen J and Zhang X:
Polysaccharides in Lentinus edodes: Isolation, structure,
immunomodulating activity and future prospective. Crit Rev Food Sci
Nutr. 54:474–487. 2014. View Article : Google Scholar
|
|
10
|
Bisen PS, Baghel RK, Sanodiya BS, Thakur
GS and Prasad GB: Lentinus edodes: A macrofungus with
pharmacological activities. Curr Med Chem. 17:2419–2430. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Zhong M, Liu B, Sha L, Lun Y,
Zhang W, Li X, Wang X, Cao J, Ning A, et al: Expression and
functional analysis of novel molecule - Latcripin-13 domain from
Lentinula edodes C91-3 produced in prokaryotic
expression system. Gene. 555:469–475. 2015. View Article : Google Scholar
|
|
12
|
Bienz M: The PHD finger, a nuclear
protein-interaction domain. Trends Biochem Sci. 31:35–40. 2006.
View Article : Google Scholar
|
|
13
|
Yamaguchi R and Newpor J: A role for
Ran-GTP and Crm1 in blocking re-replication. Cell. 113:115–125.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lim D, Park HU, De Castro L, Kang SG, Lee
HS, Jensen S, Lee KJ and Strynadka NCJ: Crystal structure and
kinetic analysis of beta-lactamase inhibitor protein-II in complex
with TEM-1 beta-lactamase. Nat Struct Biol. 8:848–852. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fryszczyn BG, Adamski CJ, Brown NG, Rice
K, Huang W and Palzkill T: Role of β-lactamase residues in a common
interface for binding the structurally unrelated inhibitory
proteins BLIP and BLIP-II. Protein Sci. 23:1235–1246. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernardi A, Frozza RL, Hoppe JB, Salbego
C, Pohlmann AR, Battastini AM and Guterres SS: The
antiproliferative effect of indomethacin-loaded lipid-core
nanocapsules in glioma cells is mediated by cell cycle regulation,
differentiation, and the inhibition of survival pathways. Int J
Nanomedicine. 8:711–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blagosklonny MV and Pardee AB: The
restriction point of the cell cycle. Cell Cycle. 1:103–110. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giacinti C and Giordano A: RB and cell
cycle progression. Oncogene. 25:5220–5227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Caldon CE, Sutherland RL and Musgrove E:
Cell cycle proteins in epithelial cell differentiation:
Implications for breast cancer. Cell Cycle. 9:1918–1928. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pines J: Four-dimensional control of the
cell cycle. Nat Cell Biol. 1:E73–E79. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsieh TC, Yang CJ, Lin CY, Lee YS and Wu
JM: Control of stability of cyclin D1 by quinone reductase 2 in
CWR22Rv1 prostate cancer cells. Carcinogenesis. 33:670–677. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Embi N, Rylatt DB and Cohen P: Glycogen
synthase kinase-3 from rabbit skeletal muscle. Separation from
cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J
Biochem. 107:519–527. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Troussard AA, Tan C, Yoganathan TN and
Dedhar S: Cell-extracellular matrix interactions stimulate the AP-1
transcription factor in an integrin-linked kinase- and glycogen
synthase kinase 3-dependent manner. Mol Cell Biol. 19:7420–7427.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Turenne GA and Price BD: Glycogen synthase
kinase3 beta phosphorylates serine 33 of p53 and activates p53's
transcriptional activity. BMC Cell Biol. 2:122001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takahashi-Yanaga F and Sasaguri T:
GSK-3beta regulates cyclin D1 expression: A new target for
chemotherapy. Cell Signal. 20:581–589. 2008. View Article : Google Scholar
|
|
26
|
Haq S, Choukroun G, Kang ZB, Ranu H,
Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J,
Hajjar R, et al: Glycogen synthase kinase-3beta is a negative
regulator of cardiomyocyte hypertrophy. J Cell Biol. 151:117–130.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Antos CL, McKinsey TA, Frey N, Kutschke W,
McAnally J, Shelton JM, Richardson JA, Hill JA and Olson EN:
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy
in vivo. Proc Natl Acad Sci USA. 99:907–912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van de Schans VA, van den Borne SW,
Strzelecka AE, Janssen BJ, van der Velden JL, Langen RC,
Wynshaw-Boris A, Smits JF and Blankesteijn WM: Interruption of Wnt
signaling attenuates the onset of pressure overload-induced cardiac
hypertrophy. Hypertension. 49:473–480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martinez A, Castro A, Dorronsoro I and
Alonso M: Glycogen synthase kinase 3 (GSK-3) inhibitors as new
promising drugs for diabetes, neurodegeneration, cancer, and
inflammation. Med Res Rev. 22:373–384. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Diehl JA, Zindy F and Sherr CJ: Inhibition
of cyclin D1 phosphorylation on threonine-286 prevents its rapid
degradation via the ubiquitin-proteasome pathway. Genes Dev.
11:957–972. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Diehl JA, Cheng M, Roussel MF and Sherr
CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis
and subcellular localization. Genes Dev. 12:3499–3511. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lawen A: Apoptosis - an introduction.
Bioessays. 25:888–896. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Robertson JD and Orrenius S: Molecular
mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev
Toxicol. 30:609–627. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zimmermann KC, Bonzon C and Green DR: The
machinery of programmed cell death. Pharmacol Ther. 92:57–70. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jourdan M, Reme T, Goldschmidt H, Fiol G,
Pantesco V, De Vos J, Rossi JF, Hose D and Klein B: Gene expression
of anti- and pro-apoptotic proteins in malignant and normal plasma
cells. Br J Haematol. 145:45–58. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu W and Kavanagh JJ: Anticancer therapy
targeting the apoptotic pathway. Lancet Oncol. 4:721–729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gupta S: Molecular steps of death receptor
and mitochondrial pathways of apoptosis. Life Sci. 69:2957–2964.
2001. View Article : Google Scholar
|
|
38
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lei JC, Yu JQ, Yin Y, Liu YW and Zou G:
Alantolactone induces activation of apoptosis in human hepatoma
cells. Food Chem Toxicol. 50:3313–3319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Q, Wu J, Hu Z and Li D: Induction of
HL-60 apoptosis by ethyl acetate extract of Cordyceps sinensis
fungal mycelium. Life Sci. 75:2911–2919. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Makde RD, England JR, Yennawar HP and Tan
S: Structure of RCC1 chromatin factor bound to the nucleosome core
particle. Nature. 467:562–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wong CH, Chan H, Ho CY, Lai SK, Chan KS,
Koh CG and Li HY: Apoptotic histone modification inhibits nuclear
transport by regulating RCC1. Nat Cell Biol. 11:36–45. 2009.
View Article : Google Scholar
|
